Global Etoricoxib Tablet Market Growth 2022-2028
Etoricoxib is used to reduce inflammation (swelling) and relieve pain in arthritic conditions such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
The global market for Etoricoxib Tablet is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Etoricoxib Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Etoricoxib Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Etoricoxib Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Etoricoxib Tablet market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Etoricoxib Tablet players cover Merk, AdvaCare, Alpha Drugs, BSA Pharma Inc. and Vibcare Pharma Pvt Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Etoricoxib Tablet market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Etoricoxib Tablet market, with both quantitative and qualitative data, to help readers understand how the Etoricoxib Tablet market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Etoricoxib Tablet market and forecasts the market size by Type (60mg, 90mg and 120mg), by Application (Osteoarthritis (OA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
60mg
90mg
120mg
Segmentation by application
Osteoarthritis (OA)
Rheumatoid Arthritis (RA)
Ankylosing Spondylitis
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Merk
AdvaCare
Alpha Drugs
BSA Pharma Inc.
Vibcare Pharma Pvt Ltd
WELLONA PHARMA
Incepta Pharmaceuticals Ltd.
LXIR Medilabs
Swissche Healthcare
MK Medicine
QILU PHARMACEUTICAL CO.,LTD
Chapter Introduction
Chapter 1: Scope of Etoricoxib Tablet, Research Methodology, etc.
Chapter 2: Executive Summary, global Etoricoxib Tablet market size (sales and revenue) and CAGR, Etoricoxib Tablet market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Etoricoxib Tablet sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Etoricoxib Tablet sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Etoricoxib Tablet market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Merk, AdvaCare, Alpha Drugs, BSA Pharma Inc., Vibcare Pharma Pvt Ltd, WELLONA PHARMA, Incepta Pharmaceuticals Ltd., LXIR Medilabs and Swissche Healthcare, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Etoricoxib Tablet Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Etoricoxib Tablet by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Etoricoxib Tablet by Country/Region, 2017, 2022 & 2028
2.2 Etoricoxib Tablet Segment by Type
2.2.1 60mg
2.2.2 90mg
2.2.3 120mg
2.3 Etoricoxib Tablet Sales by Type
2.3.1 Global Etoricoxib Tablet Sales Market Share by Type (2017-2022)
2.3.2 Global Etoricoxib Tablet Revenue and Market Share by Type (2017-2022)
2.3.3 Global Etoricoxib Tablet Sale Price by Type (2017-2022)
2.4 Etoricoxib Tablet Segment by Application
2.4.1 Osteoarthritis (OA)
2.4.2 Rheumatoid Arthritis (RA)
2.4.3 Ankylosing Spondylitis
2.4.4 Others
2.5 Etoricoxib Tablet Sales by Application
2.5.1 Global Etoricoxib Tablet Sale Market Share by Application (2017-2022)
2.5.2 Global Etoricoxib Tablet Revenue and Market Share by Application (2017-2022)
2.5.3 Global Etoricoxib Tablet Sale Price by Application (2017-2022)
3 Global Etoricoxib Tablet by Company
3.1 Global Etoricoxib Tablet Breakdown Data by Company
3.1.1 Global Etoricoxib Tablet Annual Sales by Company (2020-2022)
3.1.2 Global Etoricoxib Tablet Sales Market Share by Company (2020-2022)
3.2 Global Etoricoxib Tablet Annual Revenue by Company (2020-2022)
3.2.1 Global Etoricoxib Tablet Revenue by Company (2020-2022)
3.2.2 Global Etoricoxib Tablet Revenue Market Share by Company (2020-2022)
3.3 Global Etoricoxib Tablet Sale Price by Company
3.4 Key Manufacturers Etoricoxib Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etoricoxib Tablet Product Location Distribution
3.4.2 Players Etoricoxib Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Etoricoxib Tablet by Geographic Region
4.1 World Historic Etoricoxib Tablet Market Size by Geographic Region (2017-2022)
4.1.1 Global Etoricoxib Tablet Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Etoricoxib Tablet Annual Revenue by Geographic Region
4.2 World Historic Etoricoxib Tablet Market Size by Country/Region (2017-2022)
4.2.1 Global Etoricoxib Tablet Annual Sales by Country/Region (2017-2022)
4.2.2 Global Etoricoxib Tablet Annual Revenue by Country/Region
4.3 Americas Etoricoxib Tablet Sales Growth
4.4 APAC Etoricoxib Tablet Sales Growth
4.5 Europe Etoricoxib Tablet Sales Growth
4.6 Middle East & Africa Etoricoxib Tablet Sales Growth
5 Americas
5.1 Americas Etoricoxib Tablet Sales by Country
5.1.1 Americas Etoricoxib Tablet Sales by Country (2017-2022)
5.1.2 Americas Etoricoxib Tablet Revenue by Country (2017-2022)
5.2 Americas Etoricoxib Tablet Sales by Type
5.3 Americas Etoricoxib Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etoricoxib Tablet Sales by Region
6.1.1 APAC Etoricoxib Tablet Sales by Region (2017-2022)
6.1.2 APAC Etoricoxib Tablet Revenue by Region (2017-2022)
6.2 APAC Etoricoxib Tablet Sales by Type
6.3 APAC Etoricoxib Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Etoricoxib Tablet by Country
7.1.1 Europe Etoricoxib Tablet Sales by Country (2017-2022)
7.1.2 Europe Etoricoxib Tablet Revenue by Country (2017-2022)
7.2 Europe Etoricoxib Tablet Sales by Type
7.3 Europe Etoricoxib Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Etoricoxib Tablet by Country
8.1.1 Middle East & Africa Etoricoxib Tablet Sales by Country (2017-2022)
8.1.2 Middle East & Africa Etoricoxib Tablet Revenue by Country (2017-2022)
8.2 Middle East & Africa Etoricoxib Tablet Sales by Type
8.3 Middle East & Africa Etoricoxib Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etoricoxib Tablet
10.3 Manufacturing Process Analysis of Etoricoxib Tablet
10.4 Industry Chain Structure of Etoricoxib Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etoricoxib Tablet Distributors
11.3 Etoricoxib Tablet Customer
12 World Forecast Review for Etoricoxib Tablet by Geographic Region
12.1 Global Etoricoxib Tablet Market Size Forecast by Region
12.1.1 Global Etoricoxib Tablet Forecast by Region (2023-2028)
12.1.2 Global Etoricoxib Tablet Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Etoricoxib Tablet Forecast by Type
12.7 Global Etoricoxib Tablet Forecast by Application
13 Key Players Analysis
13.1 Merk
13.1.1 Merk Company Information
13.1.2 Merk Etoricoxib Tablet Product Offered
13.1.3 Merk Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merk Main Business Overview
13.1.5 Merk Latest Developments
13.2 AdvaCare
13.2.1 AdvaCare Company Information
13.2.2 AdvaCare Etoricoxib Tablet Product Offered
13.2.3 AdvaCare Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AdvaCare Main Business Overview
13.2.5 AdvaCare Latest Developments
13.3 Alpha Drugs
13.3.1 Alpha Drugs Company Information
13.3.2 Alpha Drugs Etoricoxib Tablet Product Offered
13.3.3 Alpha Drugs Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Alpha Drugs Main Business Overview
13.3.5 Alpha Drugs Latest Developments
13.4 BSA Pharma Inc.
13.4.1 BSA Pharma Inc. Company Information
13.4.2 BSA Pharma Inc. Etoricoxib Tablet Product Offered
13.4.3 BSA Pharma Inc. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BSA Pharma Inc. Main Business Overview
13.4.5 BSA Pharma Inc. Latest Developments
13.5 Vibcare Pharma Pvt Ltd
13.5.1 Vibcare Pharma Pvt Ltd Company Information
13.5.2 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Product Offered
13.5.3 Vibcare Pharma Pvt Ltd Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Vibcare Pharma Pvt Ltd Main Business Overview
13.5.5 Vibcare Pharma Pvt Ltd Latest Developments
13.6 WELLONA PHARMA
13.6.1 WELLONA PHARMA Company Information
13.6.2 WELLONA PHARMA Etoricoxib Tablet Product Offered
13.6.3 WELLONA PHARMA Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 WELLONA PHARMA Main Business Overview
13.6.5 WELLONA PHARMA Latest Developments
13.7 Incepta Pharmaceuticals Ltd.
13.7.1 Incepta Pharmaceuticals Ltd. Company Information
13.7.2 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Product Offered
13.7.3 Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Incepta Pharmaceuticals Ltd. Main Business Overview
13.7.5 Incepta Pharmaceuticals Ltd. Latest Developments
13.8 LXIR Medilabs
13.8.1 LXIR Medilabs Company Information
13.8.2 LXIR Medilabs Etoricoxib Tablet Product Offered
13.8.3 LXIR Medilabs Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 LXIR Medilabs Main Business Overview
13.8.5 LXIR Medilabs Latest Developments
13.9 Swissche Healthcare
13.9.1 Swissche Healthcare Company Information
13.9.2 Swissche Healthcare Etoricoxib Tablet Product Offered
13.9.3 Swissche Healthcare Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Swissche Healthcare Main Business Overview
13.9.5 Swissche Healthcare Latest Developments
13.10 MK Medicine
13.10.1 MK Medicine Company Information
13.10.2 MK Medicine Etoricoxib Tablet Product Offered
13.10.3 MK Medicine Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 MK Medicine Main Business Overview
13.10.5 MK Medicine Latest Developments
13.11 QILU PHARMACEUTICAL CO.,LTD
13.11.1 QILU PHARMACEUTICAL CO.,LTD Company Information
13.11.2 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Product Offered
13.11.3 QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 QILU PHARMACEUTICAL CO.,LTD Main Business Overview
13.11.5 QILU PHARMACEUTICAL CO.,LTD Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Etoricoxib Tablet Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Etoricoxib Tablet Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 60mg
Table 4. Major Players of 90mg
Table 5. Major Players of 120mg
Table 6. Global Etoricoxib Tablet Sales by Type (2017-2022) & (K Units)
Table 7. Global Etoricoxib Tablet Sales Market Share by Type (2017-2022)
Table 8. Global Etoricoxib Tablet Revenue by Type (2017-2022) & ($ million)
Table 9. Global Etoricoxib Tablet Revenue Market Share by Type (2017-2022)
Table 10. Global Etoricoxib Tablet Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Etoricoxib Tablet Sales by Application (2017-2022) & (K Units)
Table 12. Global Etoricoxib Tablet Sales Market Share by Application (2017-2022)
Table 13. Global Etoricoxib Tablet Revenue by Application (2017-2022)
Table 14. Global Etoricoxib Tablet Revenue Market Share by Application (2017-2022)
Table 15. Global Etoricoxib Tablet Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Etoricoxib Tablet Sales by Company (2020-2022) & (K Units)
Table 17. Global Etoricoxib Tablet Sales Market Share by Company (2020-2022)
Table 18. Global Etoricoxib Tablet Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Etoricoxib Tablet Revenue Market Share by Company (2020-2022)
Table 20. Global Etoricoxib Tablet Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Etoricoxib Tablet Producing Area Distribution and Sales Area
Table 22. Players Etoricoxib Tablet Products Offered
Table 23. Etoricoxib Tablet Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Etoricoxib Tablet Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Etoricoxib Tablet Sales Market Share Geographic Region (2017-2022)
Table 28. Global Etoricoxib Tablet Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Etoricoxib Tablet Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Etoricoxib Tablet Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Etoricoxib Tablet Sales Market Share by Country/Region (2017-2022)
Table 32. Global Etoricoxib Tablet Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Etoricoxib Tablet Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Etoricoxib Tablet Sales by Country (2017-2022) & (K Units)
Table 35. Americas Etoricoxib Tablet Sales Market Share by Country (2017-2022)
Table 36. Americas Etoricoxib Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Etoricoxib Tablet Revenue Market Share by Country (2017-2022)
Table 38. Americas Etoricoxib Tablet Sales by Type (2017-2022) & (K Units)
Table 39. Americas Etoricoxib Tablet Sales Market Share by Type (2017-2022)
Table 40. Americas Etoricoxib Tablet Sales by Application (2017-2022) & (K Units)
Table 41. Americas Etoricoxib Tablet Sales Market Share by Application (2017-2022)
Table 42. APAC Etoricoxib Tablet Sales by Region (2017-2022) & (K Units)
Table 43. APAC Etoricoxib Tablet Sales Market Share by Region (2017-2022)
Table 44. APAC Etoricoxib Tablet Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Etoricoxib Tablet Revenue Market Share by Region (2017-2022)
Table 46. APAC Etoricoxib Tablet Sales by Type (2017-2022) & (K Units)
Table 47. APAC Etoricoxib Tablet Sales Market Share by Type (2017-2022)
Table 48. APAC Etoricoxib Tablet Sales by Application (2017-2022) & (K Units)
Table 49. APAC Etoricoxib Tablet Sales Market Share by Application (2017-2022)
Table 50. Europe Etoricoxib Tablet Sales by Country (2017-2022) & (K Units)
Table 51. Europe Etoricoxib Tablet Sales Market Share by Country (2017-2022)
Table 52. Europe Etoricoxib Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Etoricoxib Tablet Revenue Market Share by Country (2017-2022)
Table 54. Europe Etoricoxib Tablet Sales by Type (2017-2022) & (K Units)
Table 55. Europe Etoricoxib Tablet Sales Market Share by Type (2017-2022)
Table 56. Europe Etoricoxib Tablet Sales by Application (2017-2022) & (K Units)
Table 57. Europe Etoricoxib Tablet Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Etoricoxib Tablet Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Etoricoxib Tablet Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Etoricoxib Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Etoricoxib Tablet Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Etoricoxib Tablet Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Etoricoxib Tablet Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Etoricoxib Tablet Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Etoricoxib Tablet Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Etoricoxib Tablet
Table 67. Key Market Challenges & Risks of Etoricoxib Tablet
Table 68. Key Industry Trends of Etoricoxib Tablet
Table 69. Etoricoxib Tablet Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Etoricoxib Tablet Distributors List
Table 72. Etoricoxib Tablet Customer List
Table 73. Global Etoricoxib Tablet Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Etoricoxib Tablet Sales Market Forecast by Region
Table 75. Global Etoricoxib Tablet Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Etoricoxib Tablet Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Etoricoxib Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Etoricoxib Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Etoricoxib Tablet Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Etoricoxib Tablet Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Etoricoxib Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Etoricoxib Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Etoricoxib Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Etoricoxib Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Etoricoxib Tablet Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Etoricoxib Tablet Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Etoricoxib Tablet Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Etoricoxib Tablet Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Etoricoxib Tablet Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Etoricoxib Tablet Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Etoricoxib Tablet Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Etoricoxib Tablet Revenue Market Share Forecast by Application (2023-2028)
Table 93. Merk Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 94. Merk Etoricoxib Tablet Product Offered
Table 95. Merk Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Merk Main Business
Table 97. Merk Latest Developments
Table 98. AdvaCare Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 99. AdvaCare Etoricoxib Tablet Product Offered
Table 100. AdvaCare Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. AdvaCare Main Business
Table 102. AdvaCare Latest Developments
Table 103. Alpha Drugs Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 104. Alpha Drugs Etoricoxib Tablet Product Offered
Table 105. Alpha Drugs Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Alpha Drugs Main Business
Table 107. Alpha Drugs Latest Developments
Table 108. BSA Pharma Inc. Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 109. BSA Pharma Inc. Etoricoxib Tablet Product Offered
Table 110. BSA Pharma Inc. Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. BSA Pharma Inc. Main Business
Table 112. BSA Pharma Inc. Latest Developments
Table 113. Vibcare Pharma Pvt Ltd Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 114. Vibcare Pharma Pvt Ltd Etoricoxib Tablet Product Offered
Table 115. Vibcare Pharma Pvt Ltd Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Vibcare Pharma Pvt Ltd Main Business
Table 117. Vibcare Pharma Pvt Ltd Latest Developments
Table 118. WELLONA PHARMA Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 119. WELLONA PHARMA Etoricoxib Tablet Product Offered
Table 120. WELLONA PHARMA Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. WELLONA PHARMA Main Business
Table 122. WELLONA PHARMA Latest Developments
Table 123. Incepta Pharmaceuticals Ltd. Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 124. Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Product Offered
Table 125. Incepta Pharmaceuticals Ltd. Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Incepta Pharmaceuticals Ltd. Main Business
Table 127. Incepta Pharmaceuticals Ltd. Latest Developments
Table 128. LXIR Medilabs Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 129. LXIR Medilabs Etoricoxib Tablet Product Offered
Table 130. LXIR Medilabs Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. LXIR Medilabs Main Business
Table 132. LXIR Medilabs Latest Developments
Table 133. Swissche Healthcare Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 134. Swissche Healthcare Etoricoxib Tablet Product Offered
Table 135. Swissche Healthcare Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Swissche Healthcare Main Business
Table 137. Swissche Healthcare Latest Developments
Table 138. MK Medicine Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 139. MK Medicine Etoricoxib Tablet Product Offered
Table 140. MK Medicine Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. MK Medicine Main Business
Table 142. MK Medicine Latest Developments
Table 143. QILU PHARMACEUTICAL CO.,LTD Basic Information, Etoricoxib Tablet Manufacturing Base, Sales Area and Its Competitors
Table 144. QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Product Offered
Table 145. QILU PHARMACEUTICAL CO.,LTD Etoricoxib Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. QILU PHARMACEUTICAL CO.,LTD Main Business
Table 147. QILU PHARMACEUTICAL CO.,LTD Latest Developments
List of Figures
Figure 1. Picture of Etoricoxib Tablet
Figure 2. Etoricoxib Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Etoricoxib Tablet Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Etoricoxib Tablet Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Etoricoxib Tablet Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 60mg
Figure 10. Product Picture of 90mg
Figure 11. Product Picture of 120mg
Figure 12. Global Etoricoxib Tablet Sales Market Share by Type in 2021
Figure 13. Global Etoricoxib Tablet Revenue Market Share by Type (2017-2022)
Figure 14. Etoricoxib Tablet Consumed in Osteoarthritis (OA)
Figure 15. Global Etoricoxib Tablet Market: Osteoarthritis (OA) (2017-2022) & (K Units)
Figure 16. Etoricoxib Tablet Consumed in Rheumatoid Arthritis (RA)
Figure 17. Global Etoricoxib Tablet Market: Rheumatoid Arthritis (RA) (2017-2022) & (K Units)
Figure 18. Etoricoxib Tablet Consumed in Ankylosing Spondylitis
Figure 19. Global Etoricoxib Tablet Market: Ankylosing Spondylitis (2017-2022) & (K Units)
Figure 20. Etoricoxib Tablet Consumed in Others
Figure 21. Global Etoricoxib Tablet Market: Others (2017-2022) & (K Units)
Figure 22. Global Etoricoxib Tablet Sales Market Share by Application (2017-2022)
Figure 23. Global Etoricoxib Tablet Revenue Market Share by Application in 2021
Figure 24. Etoricoxib Tablet Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Etoricoxib Tablet Revenue Market Share by Company in 2021
Figure 26. Global Etoricoxib Tablet Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Etoricoxib Tablet Revenue Market Share by Geographic Region in 2021
Figure 28. Global Etoricoxib Tablet Sales Market Share by Region (2017-2022)
Figure 29. Global Etoricoxib Tablet Revenue Market Share by Country/Region in 2021
Figure 30. Americas Etoricoxib Tablet Sales 2017-2022 (K Units)
Figure 31. Americas Etoricoxib Tablet Revenue 2017-2022 ($ Millions)
Figure 32. APAC Etoricoxib Tablet Sales 2017-2022 (K Units)
Figure 33. APAC Etoricoxib Tablet Revenue 2017-2022 ($ Millions)
Figure 34. Europe Etoricoxib Tablet Sales 2017-2022 (K Units)
Figure 35. Europe Etoricoxib Tablet Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Etoricoxib Tablet Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Etoricoxib Tablet Revenue 2017-2022 ($ Millions)
Figure 38. Americas Etoricoxib Tablet Sales Market Share by Country in 2021
Figure 39. Americas Etoricoxib Tablet Revenue Market Share by Country in 2021
Figure 40. United States Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Etoricoxib Tablet Sales Market Share by Region in 2021
Figure 45. APAC Etoricoxib Tablet Revenue Market Share by Regions in 2021
Figure 46. China Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Etoricoxib Tablet Sales Market Share by Country in 2021
Figure 53. Europe Etoricoxib Tablet Revenue Market Share by Country in 2021
Figure 54. Germany Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Etoricoxib Tablet Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Etoricoxib Tablet Revenue Market Share by Country in 2021
Figure 61. Egypt Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Etoricoxib Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Etoricoxib Tablet in 2021
Figure 67. Manufacturing Process Analysis of Etoricoxib Tablet
Figure 68. Industry Chain Structure of Etoricoxib Tablet
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets